Daniel A. Fentes-Perez - Publications

Impact of robotic access and dedicated kidney surgery teams on nephron-sparing surgery for T1 renal masses: evidence from a Spanish multicenter registry.

Journal: Journal of robotic surgery

Published: June 16, 2026

PSA Response as a Prognostic Marker in Metastatic Hormone-sensitive Prostate Cancer: Comparison with Tumor Volume (CHAARTED).

Journal: European urology open science

Published: May 01, 2026

Do aspiration-assisted access sheaths improve outcomes in miniaturized percutaneous nephrolithotomy? A systematic review and meta-analysis.

Journal: Actas urologicas espanolas

Published: April 14, 2026

Expert consensus recommendations for the management of biochemical recurrence in prostate cancer: a Delphi study across clinical scenarios.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 14, 2026

Prediction of infectious complications after supine percutaneous nephrolithotomy: development and internal validation of a multivariable nomogram.

Journal: Urolithiasis

Published: March 19, 2026

When evidence is not interchangeable: The limits of therapeutic equivalence in high-risk biochemical recurrence of prostate cancer.

Journal: Actas urologicas espanolas

Published: March 04, 2026

Effectiveness and safety of hormonal doublet therapy in metastatic hormone-sensitive prostate cancer: A multicenter real-world study.

Journal: Actas urologicas espanolas

Published: March 03, 2026

Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

Journal: The Prostate

Published: January 31, 2026

Clinical advances and practice updates in genitourinary cancers: a 2025 review from the multidisciplinary Spanish 'Cambados annual meeting'.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 16, 2026

Current management of stage T1 renal cell carcinoma in Spain: Results of a multicentre national registry.

Journal: Actas urologicas espanolas

Published: September 25, 2025

Prescription of PARP inhibitors (iPARP) in metastatic castration-resistant prostate cancer: a position paper of the Spanish Association of Urology (AEU) and its Uro-Oncology Group (GUO).

Journal: Actas urologicas espanolas

Published: September 15, 2025

Accuracy of large language models in interpreting urological clinical guidelines: a comparative study with expert evaluation.

Journal: Therapeutic advances in urology

Published: August 26, 2025